SHORT SUMMARY A U.S. national sample of gay and bisexual men completed at-home self-administered testing for urethral and rectal gonorrhea/chlamydia (GC/CT). In total 6.2% were GC/CT positive (5.3% rectal, 1.7% urethral).
Introduction
Gay, bisexual, and other men who have sex with men (GBMSM) represent 4-15% of the U.S. population (1, 2) and are disproportionally affected by sexually transmitted infections, including Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) (3, 4) . In 2013, in the U.S. STD surveillance network-comprised of 42 STD clinics within 12 collaborating jurisdictions-GC prevalence was 16.9% (range by site: 10.4%-28.1%) and CT prevalence was 15 .2% (range by site: 7.4%-30.7%) among GBMSM (4) . Across collaborating jurisdictions, 27 .4% of GC cases were estimated to be among GBMSM, 30 .5% among men who have sex with women, and 42.1% among women-comparable data on CT were not reported.
Testing for GC and CT has historically been conducted with culture, however, Nucleic Acid Amplification Tests (NAAT) (e.g., the Abbott Real-Time, Aptima COMBO 2 assay, cobas® 4800) are now recommended by the U.S. Food and Drug Administration as the standard diagnostic tests for their increased sensitivity, specificity, and ease of specimen transport (5) . The most common methods by which GC and CT are tested are through the collection of urine.
Urine-based screening allows for self-collection(6) with minimal sample collection barriers compared to urethral specimens that need to be collected in a clinic setting (7) . Patients provide a first-catch urine specimen that is transferred to a test specific transport tube. Fewer studies have examined the prevalence of rectal GC and CT, which is typically identified via a swab of the rectum and culture. NAATs are not FDA approved for rectal specimens, limiting their accessibility at private practice settings compared to public health STD clinics (8) . Patients selfswab the inside of the rectum and break off the swab into a test specific transport tube. Selfsampling has been compared to clinic-based testing finding high viability and acceptability with a variety of populations including MSM (6, 9) . Although GBMSM do not engage in anal sex every time they have sex (10) , there remains a need to test for urethral as well as rectal GC/CT given that many GBMSM do engage in insertive as well as receptive anal sex (11, 12) . Studies of GBMSM who engage in anal sex have found that rates of engaging in receptive as well as insertive anal sex (i.e., versatility) ranged from moderate (e.g., 38%(13)) to high (e.g., 73% (14) , 83%(15)), suggesting that a significant portion of GBMSM should be routinely screened for urethral as well as rectal STIs.
As a result of the continuing HIV and STI epidemics, much of researchers' attention to GBMSM has been grounded in HIV prevention. And, much of what we know about GBMSM has been based on samples in urban epicenters. As a result, less is known about U.S. GBMSM who live outside of urban centers. Although CDC surveillance data is helpful with identifying incident HIV and STIs, much of these data are limited to urban centers and/or collected at STD clinics (i.e., self-selected samples of individuals who perceive themselves to need, or are referred for, STI testing). Furthermore, surveillance data is restricted in that it provides little context as to social and behavioral factors that are associated with STI diagnoses.
With the expanded use of the Internet both by researchers as well as GBMSM, engaging geographically diverse samples of GBMSM in research has become and increasingly acceptable method of data collection (16) (17) (18) (19) (20) . Recently, researchers have begun combining online data collection with self-administered biological data collection, particularly for HIV among GBMSM (21, 22) . Less is known about the use of at-home self-administered testing for STIs among GBMSM; however studies suggest it is feasible and acceptable (9, 23) . To that end, the present study reports on rates of urethral and rectal GC/CT diagnosis in a U.S. national sample of HIV-negative GBM, as well as factors associated with urethral and rectal diagnosis.
Method

Participants and Procedures
The One Thousand Strong panel is a longitudinal study following a U.S. national sample of gay and bisexual men (GBM) for a period of three years [BLINDED FOR REVIEW](24).
Analyses for the present manuscript were based on baseline data. Participants were identified via Community Marketing and Initiatives (CMI) panel of over 45,000 LGBT individuals, over 22,000 of whom are GBM throughout the United States. CMI draws panelists from over 200 sources ranging from LGBT events to social media and non-gay identified venues/mediums (e.g., social media). Participants in the One Thousand Strong panel were targeted to represent the diversity and distribution of GBM in the U.S. population. In so doing, recruitment targets were established using data from the U.S. Census with regard to same sex households and racial and ethnic composition.
CMI emailed potential participants with a brief description of the study along with a link to a brief 2-minute survey that would determine preliminary eligibility criteria (e.g., reside in the U.S., be at least 18 years of age, be biologically male and currently identify as male, identify as gay or bisexual, report having sex with a man in the past year, self-identify as HIV-negative, willing to complete at-home self-administered rapid HIV antibody testing, willing to complete self-administered testing for urine and rectal GC/CT, able to complete assessments in English, have access to the Internet such to complete at-home online assessments, have access to a device that was capable of taking a digital photo (e.g., camera phone, digital camera), have an address to receive mail that was not a P.O. Box, and were residentially stable (i.e., have not moved more than twice in the past 6 months)). Those meeting these preliminary criteria were invited to join the study and presented with informed consent. Those consenting had their contact information and came open during transit to the lab, rectal swab inserted into the vial containing urine) and < 1% (n = 8) had to be resent a kit because it was reported as lost in the mail-either not received by participant or not received by lab after reportedly being mailed. Our attempts to resample these 30 participants were successful.
Demographic and behavioral characteristics. Participants reported demographic characteristics including race/ethnicity, education, income, age, sexual identity, whether they had used illegal drugs (cocaine, methamphetamine, ecstasy/MDMA, GHB/GBL, heroin/opiates, ketamine, crack) in the prior 3 months, and whether they had health insurance and a primary doctor. Participants also reported their sexual behavior including the number of times they engaged in receptive and/or insertive condomless anal sex (CAS) with an HIV-positive or unknown status main partner or any casual male partners in the prior 3 months.
Analytic Plan
We first describe the prevalence of rectal and urine GC/CT as well as demographic and behavioral characteristics of the sample. As appropriate, we next report unadjusted and adjusted odds ratios for the association between demographic and behavioral characteristics with testing positive for rectal or urethral CG/CT. Adjusted odds ratios accounted for the effects of education, race, age, relationship status, having health insurance, and income. Finally, using MannWhitney U tests, which account for the non-normal distribution of count variables, we reported bivariate associations between various sexual behaviors (e.g., number of anal insertive acts, number of receptive anal sex acts) and diagnosis with rectal or urethral GC/CT. Figure 1 indicates the distribution of participants across the US. Participants represented 49 of 50 states. In total, 6.2% tested positive for rectal or urethral GC/CT. Rectal STIs were more common than urethral (5.3% vs. 1.7%), and CT was more common than GC (5.3% vs. 1.8%).
Results
Nine men (0.8%) were diagnosed with both rectal and urethral STIs, 9 men (0.8%) with just a urethral STI, and 48 men (4.6%) with just a rectal STI.
- Figure 1 -- Table 1-Table 2 reports unadjusted and adjusted odds ratios for factors associated with rectal GC/CT diagnosis. Several bivariate associations were no longer significant after adjusting for the effects of other variables. These included income, relationship status, and drug use in the prior 3 months. Compared to White men, Latino men had significantly greater odds of having a rectal STI. Among men who reported anal sex, those reporting only insertive anal sex had significantly lower odds of being diagnosed with a rectal STI than men who reported both insertive and receptive sex. Recent CAS was associated with rectal STIs. There was a negative association between age and rectal GC/CT. There was a positive association between rectal GC/CT and the number of male partners in the past 12 months, the number of anal receptive acts, receptive CAS acts, and insertive CAS acts.
- Table 2-Table 3 reports unadjusted and adjusted odds ratios for factors associated with urethral GC/CT diagnosis. Age was inversely associated with urethral GC/CT diagnosis. No other demographic characteristics were associated with urethral GC/CT diagnosis. However some behavioral characteristics were. Adjusting for the effects of education, race, age, relationship status, having health insurance, and income, compared to those who said they had engaged in both insertive and receptive anal sex, those who said they engaged in only receptive anal sex had significantly lower odds of testing positive for urethral GC/CT. In addition, the number of male partners in the past 12 months was associated with increased odds of urethral GC/CT diagnosis.
Interestingly, the number of insertive and receptive anal sex acts with and without a condom were all positively associated with testing positive for urethral GC/CT (at the bivariate level);
however, these effects did not hold up after accounting for the effects of education, race, age, relationship status, having health insurance, or income.
-- Table 3 --
Discussion
Participants completed at-home self-administered STI sample collection and mailed those to a lab for analyses with minimal errors, suggesting high feasibility and acceptability for incorporating at-home self-administered STI sample collection into studies that would otherwise be entirely online. In this study 6.2% tested positive for rectal or urethral GC/CT with rectal STIs being more common than urethral (5.3% vs. 1.7%), and CT was more common than GC (5.3%
vs. 1.8%). Our rates of new diagnoses were lower than CDC surveillance; however, it is worth noting the intrinsic differences between surveillance data and our sample. Surveillance data are collected via STD clinics, and those attending clinics are likely doing so because they are experiencing symptoms of an infection. Our sample also excluded HIV-positive men, who are included in surveillance data.
We believe the discrepancy between urethral and rectal GC/CT might be a combined result of multiple variables operating at different levels of the sexual health care continuum (26) (27) (28) (29) . These include an individual's own failure to recognize the symptoms of rectal STI infection (which can include discharge or be asymptomatic) (30) relative to the more pronounced symptoms of urethral infection, and thus a patients' failure to seek out testing/treatment. Second, there may be lower acceptability-by providers and by patients-of the method by which samples for rectal STI are collected (e.g., a medical provider inserting a swab into the rectum vs.
self-collection through routine urination). Third, both patients and providers may have discomfort around discussing sexual behavior and sexual health, particularly anal sexual health.
Fourth, a failure on behalf of medical providers to suggest/provide rectal STI testing to their GBM patients as a part of his routine medical care as well as a failure on behalf of patients to request it. Fifth, there may be insurance coverage gaps whereby routine testing for urethral STIs is covered but rectal STIs is not. Our study did not assess frequency of STI testing nor methods of STI testing (e.g., urethral and rectal) thus cannot comment as to the extent that higher rates of rectal STIs are a factor of one of the aforementioned hypotheses. In addition, we did not collect data on perceived STI symptoms (e.g., pain, discharge), which would have been useful for the present study.
In our study, STI diagnoses appeared to be more so a factor of behavioral as opposed to demographic characteristics. That is, and perhaps unsurprising, men who reported a history of CAS were more likely to also be diagnosed with GC/CT, and there was a positive association between number of male partners in the prior 12 months and GC/CT diagnoses. Although it may seem counterintuitive that, for example, receptive CAS acts were associated with urethral CT/GC, we highlight that receptive CAS was positively correlated with insertive CAS.
Limitations
Although we used parameters taken from the Census to establish recruitment targets (e.g., geographic distribution of same-sex male couples, age, race and ethnicity), this was based on data on same-sex households (i.e., couples). The Census does not collect data on sexual identity or sexual behavior, thus the true prevalence/distribution of GBM across the U.S. remains unknown. It is possible to weight our data to correct for deviation in our sample (with regard to characteristics such as race and ethnicity, geographic diversity, and age), but this requires for the population characteristics to be known. Certainly other datasets could also be used for post hoc sample weights (e.g., CDC surveillance data); however, we also highlight that adding sample weights to match our dataset to CDC surveillance data simply corrects for our sample to match another sample, not to a population.
We used the Abbott m2000 Real-Time assay for detecting STI infection. This test is shelf stable using the multi-Collect Specimen Collection kit and samples can be stored at room temperature for up 14 days. The method of detection was a NAAT PCR, which has a sensitivity of 95.2% for CT/ 98.7% for GC and a specificity of 99.3% for CT/ 99.2% for GC, thus the chances of a false positive and false negative are low(5). We recognize that other methods of STI detection exist, including the BD ProbeTec ET CT/GC Amplified DNA Assay (Becton Dickinson and Company, Sparks, MD); however, this too is not without limitations (e.g., decreased specificity due to cross-reactivity with genes from related GC species). Further, we tested only for GC/CT, but not other STIs such as genital warts, genital herpes, or syphilis. These
STIs are detected via blood draw, which would not have been feasible for the present study.
Further, we did not assess for pharyngeal infections.
By partnering with CMI to enroll members from their LGBT panel, we were able to engage a population that is already attuned to participating in web-based studies. This ensures participants are familiar with, for example, how to complete a survey online as well as how to use a computer. Individuals who do not know how to use a computer or do not have Internet access would not be eligible to be a CMI panelist and thus would not be represented in this present study. This bias toward a more technologically savvy population should be noted.
Conclusions
The One Thousand Strong panel is prospectively following 1,071 HIV-negative GBM from across the United States. In addition to online components, we were able to engage the panel in self-administered at-home STI testing and only a small proportion of potential participants failed to complete these procedures. This suggests that there is high feasibility and acceptability in incorporating self-administered STI testing into research studies that would be otherwise fully online. Rectal GC/CT was more common than urethral and associated with some demographic and behavioral characteristics. Our finding that insertive CAS acts was associated with rectal GC/CT highlights the importance for providers to screen patients for GC/CT via a full range of transmission routes, lest GC/CT go undiagnosed. 
